NCT07760649Not yet recruiting
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke
A Post-market Observational Study to Monitor Safety and Effectiveness in the Treatment of Patients With Ischemic Stroke Using Commercially Approved J&J MedTech Devices Optimized for Neurovascular Thrombectomy
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
The purpose of this study is to collect medical information to monitor the ongoing safety of the J\&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 7 Aug 2026
- Start date
- 23 Sept 2026
- Primary completion date
- 16 Oct 2030
- Lead sponsor
- Neuravi Limited
- Diseases
- Stroke
- NCT number
- NCT07760649
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 23 Sept 2026 to the primary completion date, 16 Oct 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current involvement in an investigational (drug, device, etcetera) clinical study that may confound study endpoints. Sponsor approval is required prior to enrollment
Other
- Known pregnancy, as evidenced by positive pregnancy test for women of childbearing potential or breast feeding
Who the study is looking for
- Participant is 18 years of age or older at the time of consent
- Informed Consent has been provided by the participant or the participants' legally authorized representative (LAR)
- Participants with angiographic confirmation of acute ischemic stroke
- A clinical decision has been made to treat the participant with an eligible Johnson \& Johnson MedTech neuro-thrombectomy device independently and prior to enrollment in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.